Guardant Health Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
/ 
Frequently asked questions
To buy Guardant Health Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Guardant Health Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Guardant Health Inc. is GH:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Guardant Health Inc. has its primary listing on NASDAQ. You can trade Guardant Health Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Guardant Health Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Guardant Health Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Guardant Health Inc..